You are here: Industry Insights > Collaboration

News List

PPD, Frenova in Nephrology Services Collaboration contractpharma
February 23, 2017
Will leverage Frenova’s therapeutic expertise, data access, study startup times
Sobi expands haemophilia B development portfolio by adding rFIXFc-XTEN to its collaboration agreemen firstwordpharma
February 21, 2017
Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces that it has elected to add a novel product candidate (rFIXFc-XTEN) for the potential treatment of haemophilia B to the company’s collaboration agreement with Bioverativ.
Incyte and Agenus Amend Collaboration Agreement firstwordpharma
February 15, 2017
Incyte Corporation and Agenus Inc. announced today that the companies have amended the License, Development and Commercialization Agreement that was originally entered into January 9, 2015.
Owlstone Medical commences 1,400 patient clinical trial for early detection of colorectal cancer pharmaasia
February 13, 2017
World’s largest breath-based study into colorectal (bowel) cancer will be run in collaboration with the University of Warwick and the University Hospital Coventry and Warwickshire NHS Trust.
Optibrium and eMolecules collaborate on chemistry data integration in StarDrop pharmaasia
February 08, 2017
Combining eMolecules’ collection of commercially available chemicals with StarDrop’s data analysis and compound design capabilities in drug discovery.
The Austrian Center of Industrial Biotechnology collaborates with GE Healthcare biospectrumasia
February 08, 2017
The goal of the three-year partnership is to explore and identify new tools and methods to modify and optimize the Chinese hamster ovary (CHO) cell line performance
Merus closes global strategic research collaboration with Incyte pharmaceutical-technology
January 26, 2017
Netherlands-based Immuno-oncology company Merus has closed its previously announced global strategic research collaboration with Incyte.
Enamine, Actelion Expand Drug Discovery Collaboration contractpharma
January 24, 2017
Actelion to provide library synthesis and medicinal chemistry services
Ultragenyx and Kyowa Kirin International announce Marketing Authorisation Application for KRN23 pharmaasia
January 23, 2017
Since August 2013, Ultragenyx and Kyowa Hakko Kirin entered into a collaboration and license agreement to develop and commercialise KRN23.
Australia’s Telix completes product collaboration agreement with Atlab Pharma pharmaceutical-technology
January 22, 2017
Australia’s Telix Pharmaceuticals has completed a product collaboration and purchase option agreement with Atlab Pharma.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page